Do real-world data demonstrate that secukinumab is safe and effective for use in ankylosing spondylitis? Dr Adeola Ajibade joins Dr Ai Lyn Tan to discuss her recent paper - a multicentre, retrospective record-based review of the efficacy and safety of secukinumab in patients with ankylosing spondylitis across centres in the UK.Dr Ajibade is currently a specialist grade doctor at Taunton & Somerset NHS Foundation Trust. The work discussed in this episode took place during her time at the Royal Wolverhampton Hospitals NHS Trust as part of the Midlands Ankylosing Spondylitis Collaboration. Read the full article: Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC)Keywords: secukinumab, ankylosing spondylitis, spondyloarthritis, spine, rheumatology, rheumatologist, DMARD, biologic, biologic therapy, real-world data.Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram. Want to read more of our research? Explore Rheumatology and Rheumatology Advances in Practice.